Genetic Technologies Ltd (GENE.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2018||Non-Executive Chairman of the Board, Acting Chief Executive Officer|
|2016||Chief Financial Officer, Company Secretary|
|50||2014||President of Phenogen Sciences Inc|
|57||2012||Director of Global Licensing and Intellectual Property|
- BRIEF-Genetic Technologies Enters Into A Non-Binding Terms Sheet With Omix Ventures Private
- BRIEF-Genetic Technologies Says H1 Comprehensive Loss Attributable $3.3 Mln
- BRIEF-Genetic Technologies Enters Terms Sheet With Blockchain Global
- BRIEF-Genetic Technologies Says Eutillio Buccilli To Step Down As CEO
- BRIEF-Genetic Technologies Appointed Paul A. Kasian As Chairman